A double-blind, randomized, comparative study of the use of a combination of uridine triphosphate trisodium, cytidine monophosphate disodium, and hydroxocobalamin, versus isolated treatment with hydroxocobalamin, in patients presenting with compressive neuralgias
The AOD designation stands for Anti-Obesity Drug, reflecting the original research focus of the compounds development
Compare cost, convenience, and care to pick the right fit for your day
Pissios P, et al
Slu-pp-332 Capsules Slu-PP-332 is a relatively new research compound, and its safety profile has been characterised only in preclinical settings
AOD-9604 10mg is preferred for established programmes with higher throughput requirements, dose-response studies, or extended experimental timelines